Global Neisseria Gonorrhoeae Infections Treatment Market Analysis 2015-2019 and Forecast 2020-2025
- 99S3550071
- 84 Pages
- February 2020
- Healthcare
The global Neisseria Gonorrhoeae Infections Treatment market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Neisseria Gonorrhoeae Infections Treatment by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Cribrostatin-6
Dalbavancin
Debio-1453
Gepotidacin Mesylate
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Allergan Plc
BioDiem Ltd
Biolytics Pharma
Debiopharm International SA
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
Merck & Co., Inc.
Paratek Pharmaceuticals, Inc.
Recce Pty Ltd
Redx Pharma Plc
Sarepta Therapeutics, Inc.
Sumitomo Dainippon Pharma Co., Ltd
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Clinic
Hospital
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Neisseria Gonorrhoeae Infections Treatment Industry
Figure Neisseria Gonorrhoeae Infections Treatment Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Neisseria Gonorrhoeae Infections Treatment
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Neisseria Gonorrhoeae Infections Treatment
1.2.2 Downstream
Table Application Segment of Neisseria Gonorrhoeae Infections Treatment
Table Global Neisseria Gonorrhoeae Infections Treatment Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Neisseria Gonorrhoeae Infections Treatment Market by Type
3.1 By Type
3.1.1 Cribrostatin-6
Table Major Company List of Cribrostatin-6
3.1.2 Dalbavancin
Table Major Company List of Dalbavancin
3.1.3 Debio-1453
Table Major Company List of Debio-1453
3.1.4 Gepotidacin Mesylate
Table Major Company List of Gepotidacin Mesylate
3.1.5 Others
Table Major Company List of Others
3.2 Market Size
Table Global Neisseria Gonorrhoeae Infections Treatment Market 2015-2019, by Type, in USD Million
Figure Global Neisseria Gonorrhoeae Infections Treatment Market Growth 2015-2019, by Type, in USD Million
Table Global Neisseria Gonorrhoeae Infections Treatment Market 2015-2019, by Type, in Volume
Figure Global Neisseria Gonorrhoeae Infections Treatment Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Neisseria Gonorrhoeae Infections Treatment Market Forecast 2020-2025, by Type, in USD Million
Table Global Neisseria Gonorrhoeae Infections Treatment Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Allergan Plc (Company Profile, Sales Data etc.)
4.1.1 Allergan Plc Profile
Table Allergan Plc Overview List
4.1.2 Allergan Plc Products & Services
4.1.3 Allergan Plc Business Operation Conditions
Table Business Operation of Allergan Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 BioDiem Ltd (Company Profile, Sales Data etc.)
4.2.1 BioDiem Ltd Profile
Table BioDiem Ltd Overview List
4.2.2 BioDiem Ltd Products & Services
4.2.3 BioDiem Ltd Business Operation Conditions
Table Business Operation of BioDiem Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Biolytics Pharma (Company Profile, Sales Data etc.)
4.3.1 Biolytics Pharma Profile
Table Biolytics Pharma Overview List
4.3.2 Biolytics Pharma Products & Services
4.3.3 Biolytics Pharma Business Operation Conditions
Table Business Operation of Biolytics Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Debiopharm International SA (Company Profile, Sales Data etc.)
4.4.1 Debiopharm International SA Profile
Table Debiopharm International SA Overview List
4.4.2 Debiopharm International SA Products & Services
4.4.3 Debiopharm International SA Business Operation Conditions
Table Business Operation of Debiopharm International SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)
4.5.1 F. Hoffmann-La Roche Ltd. Profile
Table F. Hoffmann-La Roche Ltd. Overview List
4.5.2 F. Hoffmann-La Roche Ltd. Products & Services
4.5.3 F. Hoffmann-La Roche Ltd. Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 GlaxoSmithKline Plc (Company Profile, Sales Data etc.)
4.6.1 GlaxoSmithKline Plc Profile
Table GlaxoSmithKline Plc Overview List
4.6.2 GlaxoSmithKline Plc Products & Services
4.6.3 GlaxoSmithKline Plc Business Operation Conditions
Table Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Merck & Co., Inc. (Company Profile, Sales Data etc.)
4.7.1 Merck & Co., Inc. Profile
Table Merck & Co., Inc. Overview List
4.7.2 Merck & Co., Inc. Products & Services
4.7.3 Merck & Co., Inc. Business Operation Conditions
Table Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Paratek Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.8.1 Paratek Pharmaceuticals, Inc. Profile
Table Paratek Pharmaceuticals, Inc. Overview List
4.8.2 Paratek Pharmaceuticals, Inc. Products & Services
4.8.3 Paratek Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Paratek Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Recce Pty Ltd (Company Profile, Sales Data etc.)
4.9.1 Recce Pty Ltd Profile
Table Recce Pty Ltd Overview List
4.9.2 Recce Pty Ltd Products & Services
4.9.3 Recce Pty Ltd Business Operation Conditions
Table Business Operation of Recce Pty Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Redx Pharma Plc (Company Profile, Sales Data etc.)
4.10.1 Redx Pharma Plc Profile
Table Redx Pharma Plc Overview List
4.10.2 Redx Pharma Plc Products & Services
4.10.3 Redx Pharma Plc Business Operation Conditions
Table Business Operation of Redx Pharma Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Sarepta Therapeutics, Inc. (Company Profile, Sales Data etc.)
4.11.1 Sarepta Therapeutics, Inc. Profile
Table Sarepta Therapeutics, Inc. Overview List
4.11.2 Sarepta Therapeutics, Inc. Products & Services
4.11.3 Sarepta Therapeutics, Inc. Business Operation Conditions
Table Business Operation of Sarepta Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Sumitomo Dainippon Pharma Co., Ltd (Company Profile, Sales Data etc.)
4.12.1 Sumitomo Dainippon Pharma Co., Ltd Profile
Table Sumitomo Dainippon Pharma Co., Ltd Overview List
4.12.2 Sumitomo Dainippon Pharma Co., Ltd Products & Services
4.12.3 Sumitomo Dainippon Pharma Co., Ltd Business Operation Conditions
Table Business Operation of Sumitomo Dainippon Pharma Co., Ltd (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Neisseria Gonorrhoeae Infections Treatment Sales Revenue 2015-2019, by Company, in USD Million
Table Global Neisseria Gonorrhoeae Infections Treatment Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Neisseria Gonorrhoeae Infections Treatment Sales Revenue Share in 2019, by Company, in USD Million
Table Global Neisseria Gonorrhoeae Infections Treatment Sales Volume 2015-2019, by Company, in Volume
Table Global Neisseria Gonorrhoeae Infections Treatment Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Neisseria Gonorrhoeae Infections Treatment Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Neisseria Gonorrhoeae Infections Treatment Market Concentration, in 2019
Figure Europe Neisseria Gonorrhoeae Infections Treatment Market Market Concentration, in 2019
Figure Asia-Pacific Neisseria Gonorrhoeae Infections Treatment MMarket Concentration, in 2019
Figure South America Neisseria Gonorrhoeae Infections Treatment Market Concentration, in 2019
Figure Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Clinic
Figure Neisseria Gonorrhoeae Infections Treatment Demand in Clinic , 2015-2019, in USD Million
Figure Neisseria Gonorrhoeae Infections Treatment Demand in Clinic , 2015-2019, in Volume
6.1.2 Demand in Hospital
Figure Neisseria Gonorrhoeae Infections Treatment Demand in Hospital , 2015-2019, in USD Million
Figure Neisseria Gonorrhoeae Infections Treatment Demand in Hospital , 2015-2019, in Volume
6.1.3 Demand in Others
Figure Neisseria Gonorrhoeae Infections Treatment Demand in Others, 2015-2019, in USD Million
Figure Neisseria Gonorrhoeae Infections Treatment Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Neisseria Gonorrhoeae Infections Treatment Demand Forecast 2020-2025, by Application, in USD Million
Figure Neisseria Gonorrhoeae Infections Treatment Market Growth 2020-2025, by Application, in USD Million
Figure Neisseria Gonorrhoeae Infections Treatment Market Share in 2025, by Application, in USD Million
Table Neisseria Gonorrhoeae Infections Treatment Demand Forecast 2020-2025, by Application, in Volume
Table Neisseria Gonorrhoeae Infections Treatment Market Growth 2020-2025, by Application, in Volume
Table Neisseria Gonorrhoeae Infections Treatment Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Neisseria Gonorrhoeae Infections Treatment Production 2015-2019, by Region, in USD Million
Table Neisseria Gonorrhoeae Infections Treatment Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Neisseria Gonorrhoeae Infections Treatment Market 2015-2019, by Region, in USD Million
Table Global Neisseria Gonorrhoeae Infections Treatment Market Share 2015-2019, by Region, in USD Million
Table Global Neisseria Gonorrhoeae Infections Treatment Market 2015-2019, by Region, in Volume
Table Global Neisseria Gonorrhoeae Infections Treatment Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Neisseria Gonorrhoeae Infections Treatment Market Size and Growth 2015-2019, in USD Million
Figure North America Neisseria Gonorrhoeae Infections Treatment Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2019, by Country, in USD Million
Table North America Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Neisseria Gonorrhoeae Infections Treatment Market Size and Growth 2015-2019, in USD Million
Figure Europe Neisseria Gonorrhoeae Infections Treatment Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2019, by Country, in USD Million
Table Europe Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Neisseria Gonorrhoeae Infections Treatment Market Size and Growth 2015-2019, in USD Million
Figure South America Neisseria Gonorrhoeae Infections Treatment Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2019, by Country, in USD Million
Table South America Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Neisseria Gonorrhoeae Infections Treatment Market Forecast 2020-2025, by Region, in USD Million
Table Neisseria Gonorrhoeae Infections Treatment Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
Table Upstream Segment of Neisseria Gonorrhoeae Infections Treatment
Table Application Segment of Neisseria Gonorrhoeae Infections Treatment
Table Global Neisseria Gonorrhoeae Infections Treatment Market 2015-2025, by Application, in USD Million
Table Major Company List of Dalbavancin
Table Major Company List of Debio-1453
Table Major Company List of Gepotidacin Mesylate
Table Major Company List of Others
Table Global Neisseria Gonorrhoeae Infections Treatment Market 2015-2019, by Type, in USD Million
Table Global Neisseria Gonorrhoeae Infections Treatment Market 2015-2019, by Type, in Volume
Table Global Neisseria Gonorrhoeae Infections Treatment Market Forecast 2020-2025, by Type, in USD Million
Table Global Neisseria Gonorrhoeae Infections Treatment Market Forecast 2020-2025, by Type, in Volume
Table Allergan Plc Overview List
Table Business Operation of Allergan Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BioDiem Ltd Overview List
Table Business Operation of BioDiem Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biolytics Pharma Overview List
Table Business Operation of Biolytics Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Debiopharm International SA Overview List
Table Business Operation of Debiopharm International SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche Ltd. Overview List
Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Plc Overview List
Table Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co., Inc. Overview List
Table Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Paratek Pharmaceuticals, Inc. Overview List
Table Business Operation of Paratek Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Recce Pty Ltd Overview List
Table Business Operation of Recce Pty Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Redx Pharma Plc Overview List
Table Business Operation of Redx Pharma Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sarepta Therapeutics, Inc. Overview List
Table Business Operation of Sarepta Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sumitomo Dainippon Pharma Co., Ltd Overview List
Table Business Operation of Sumitomo Dainippon Pharma Co., Ltd (Sales Revenue, Cost, Gross Margin)
Table Global Neisseria Gonorrhoeae Infections Treatment Sales Revenue 2015-2019, by Company, in USD Million
Table Global Neisseria Gonorrhoeae Infections Treatment Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Neisseria Gonorrhoeae Infections Treatment Sales Volume 2015-2019, by Company, in Volume
Table Global Neisseria Gonorrhoeae Infections Treatment Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Neisseria Gonorrhoeae Infections Treatment Demand Forecast 2020-2025, by Application, in USD Million
Table Neisseria Gonorrhoeae Infections Treatment Demand Forecast 2020-2025, by Application, in Volume
Table Neisseria Gonorrhoeae Infections Treatment Market Growth 2020-2025, by Application, in Volume
Table Neisseria Gonorrhoeae Infections Treatment Market Share in 2025, by Application, in Volume
Table Neisseria Gonorrhoeae Infections Treatment Production 2015-2019, by Region, in USD Million
Table Neisseria Gonorrhoeae Infections Treatment Production 2015-2019, by Region, in Volume
Table Global Neisseria Gonorrhoeae Infections Treatment Market 2015-2019, by Region, in USD Million
Table Global Neisseria Gonorrhoeae Infections Treatment Market Share 2015-2019, by Region, in USD Million
Table Global Neisseria Gonorrhoeae Infections Treatment Market 2015-2019, by Region, in Volume
Table Global Neisseria Gonorrhoeae Infections Treatment Market Share 2015-2019, by Region, in Volume
Table North America Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2019, by Country, in USD Million
Table North America Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2019, by Country, in Volume
Table Europe Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2019, by Country, in USD Million
Table Europe Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2019, by Country, in Volume
Table South America Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2019, by Country, in USD Million
Table South America Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2019, by Country, in Volume
Table Neisseria Gonorrhoeae Infections Treatment Market Forecast 2020-2025, by Region, in USD Million
Table Neisseria Gonorrhoeae Infections Treatment Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
